PX458 V3 Citations (3)

Originally described in: Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reduction.
Chey YCJ, Gierus L, Lushington C, Arudkumar JC, B Geiger A, Staker LG, Robertson LJ, Pfitzner C, Kennedy JG, Lee RHB, Godahewa GI, Adikusuma F, Thomas PQ BMC Genomics. 2025 Feb 12;26(1):138. doi: 10.1186/s12864-025-11317-2. PubMed Journal

---

Articles Citing PX458 V3

Articles
Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. Wang X, Song X, Li Y, Ding Y, Yin C, Ren T, Zhang W. J Immunother Cancer. 2025 Jul 31;13(7):e012029. doi: 10.1136/jitc-2025-012029. PubMed
IDH1 Reprograms Nucleotide Metabolism by Inducing Chromatin Remodeling and DHODH Transcription to Drive Chemoresistance in Nasopharyngeal Carcinoma. Zhao Y, Ou C, Huang H, Wang Y, Shen J, Li Y, He Q, Han Z, Xie Y, Zhong T, Xu S, Liu N, Wang GY, Ma J, Li Y. Cancer Res. 2026 Apr 15;86(8):2004-2023. doi: 10.1158/0008-5472.CAN-25-2313. PubMed
RNF138 promotes cisplatin resistance and PD-L1-mediated immune evasion via JAK2/STAT3 activation in nasopharyngeal carcinoma. He C, Lou L, Lei Y, Wen X, Huang D, Lai H, Huang J, Zhou L, Zhang Q, Ma J, Liang Y, Qiao H, Zhang Y. Cell Rep. 2026 Jun 23;45(6):117547. doi: 10.1016/j.celrep.2026.117547. Epub 2026 Jun 11. PubMed

If you have published an article using this material, please email us at to have your article added to this page.